Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Regional Health Properties | RHE | 9. oct 2024 | 2.48 | 0.00 |
Regional Health Properties A Pref | RHE-A | 9. oct 2024 | 0.60 | 0.00 |
Regional Management | RM | 9. oct 2024 | 30.31 | 0.00 |
Regions Financial | RF | 9. oct 2024 | 22.74 | 0.00 |
Regions Financial B Pref | RF-B | 9. oct 2024 | 24.98 | 0.00 |
Regions Financial C Pref | RF-C | 9. oct 2024 | 25.06 | 0.00 |
Regions Financial E Pref | RF-E | 9. oct 2024 | 19.12 | 0.00 |
Regions Finl New Dep Shs Repstg 1100th Perp Pfd Ser F | RF-F | 9. oct 2024 | 26.23 | 0.00 |
Regis | RGS | 9. oct 2024 | 26.99 | +7.87 |
Regulus Therapeutics | RGLS | 9. oct 2024 | 1.48 | -4.52 |
Reinsurance Group of America | RGA | 9. oct 2024 | 216.36 | +1.28 |
REIT Index ETF Vanguard | VNQ | 9. oct 2024 | 94.46 | 0.00 |
Reitar Logtech | RITR | 9. oct 2024 | 4.65 | 0.00 |
Rekor Systems | REKR | 9. oct 2024 | 1.06 | -5.36 |
Relay Therapeutics | RLAY | 9. oct 2024 | 6.41 | +2.56 |
Reliance | RS | 9. oct 2024 | 283.46 | 0.00 |
Reliance Global | RELI | 9. oct 2024 | 2.16 | -4.00 |
Relmada Therapeutics | RLMD | 9. oct 2024 | 3.40 | -2.58 |
RELX ADR | RELX | 9. oct 2024 | 46.71 | +0.15 |
Remitly Global | RELY | 9. oct 2024 | 12.83 | -0.31 |
Renaissance Ipo ETF | IPO | 9. oct 2024 | 42.51 | 0.00 |
RenaissanceRe | RNR | 9. oct 2024 | 273.82 | +4.72 |
RenaissanceRe G Pref | RNR-G | 9. oct 2024 | 18.42 | 0.00 |
RenaissanceRe Holding F Pref | RNR-F | 9. oct 2024 | 24.46 | 0.00 |
Renalytix ADR | RNLX | 9. oct 2024 | 0.20 | 0.00 |
Renasant | RNST | 9. oct 2024 | 31.61 | 0.00 |
Reneo Pharmaceuticals | RPHM | 9. oct 2024 | 1.82 | 0.00 |
ReNew Energy Global A Shares | RNW | 9. oct 2024 | 5.99 | -0.08 |
Renn Fund | RCG | 9. oct 2024 | 2.13 | 0.00 |
Renovaro Biosciences | RENB | 9. oct 2024 | 0.42 | +1.87 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.